<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In a high proportion of Burkitt <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, transcription of the c-myc gene is initiated from a cryptic promoter in the first intron, creating abnormal <z:chebi fb="5" ids="33699">messenger RNA</z:chebi> molecules in which intron sequences, normally spliced out of the nascent transcripts, persist </plain></SENT>
<SENT sid="1" pm="."><plain>An antisense oligodeoxynucleotide directed against these intron sequences greatly inhibited the proliferation of Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines containing the abnormal transcripts (ST486 and JD38), but not that of cell lines containing <z:mpath ids='MPATH_458'>normal</z:mpath> c-myc transcripts (KK124) </plain></SENT>
<SENT sid="2" pm="."><plain>Flow cytometry showed a pronounced reduction in intracellular c-myc protein levels in cell lines containing aberrant myc transcripts, but no change in other cellular proteins </plain></SENT>
<SENT sid="3" pm="."><plain>Control oligonucleotide did not inhibit c-myc protein expression or growth </plain></SENT>
<SENT sid="4" pm="."><plain>These experiments provide evidence that antisense oligonucleotides targeted against <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-specific, aberrant <z:chebi fb="40" ids="33697">RNA</z:chebi> species could be effective in controlling the proliferation of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells without affecting <z:mpath ids='MPATH_458'>normal</z:mpath> cells </plain></SENT>
</text></document>